21^st Global Biomarkers and Clinical Research Summit

Immunological Biomarkers

There is a neglected requirement for approved biomarkers particular to immunotherapies that would control treatment choices particular to every patient, by maintaining a strategic distance from choice of ineffectual treatments and toxicities and counteracting components of safe getaway. It has turned out to be progressively obvious that the standards utilized for the advancement of biomarkers for customary focused on treatment may not matter to malignancy immunotherapy. The essential obstacle constraining exploration endeavors to recognize biomarkers are the unpredictability and dynamic nature of the connections between the resistant framework and tumor cells. Accordingly, understanding the complex pathobiology of cancer– safe framework cooperation’s is vital.

Challenges to biomarkers development in Immune system

Biomarkers discovery in Immunology

Biomarkers for Early Progressive Inflammatory & Immunological Diseases

Biomarkers of Disease Pathogenesis

Biomarkers under autoimmune system